The short answer
A harmful low-blood-pressure interaction between CoQ10 and terazosin has not been established. A controlled CoQ10 study on background BP treatment did not lower the main 24-hour BP measures.
What this answer covers
Oral terazosin with CoQ10 supplements; the inspected trial used 100 mg twice daily with unchanged background antihypertensive treatment.
- Supplement or preparation
- Coenzyme Q10
- Medication ingredient
- terazosin
What the controlled study found
Thirty adults with metabolic syndrome and inadequately controlled BP took CoQ10 or placebo in a crossover trial. CoQ10 did not significantly lower the primary 24-hour systolic or diastolic measures, although some secondary diastolic-load measures improved. No clinically relevant safety changes were reported.
Why this does not settle every combination
The study did not identify a terazosin subgroup and does not prove that every formulation or patient will respond the same way. It also does not justify labeling the combination as a demonstrated cause of fainting. Terazosin itself has a clear postural-hypotension warning.
Review the reason and dose
Bring the CoQ10 product and daily dose to your pharmacist or prescriber. Do not use the trial dose as a recommendation, replace terazosin with CoQ10, or assume a spacing rule is needed. Decisions can be based on your clinical reason for supplementation and BP symptoms.
Respond to symptoms
Terazosin can cause dizziness, lightheadedness or fainting, particularly when treatment begins or the dose changes. Report troublesome symptoms to the prescriber; sit or lie down if you feel faint and avoid hazardous activity while affected. A blood-pressure reading and the timing of symptoms can help distinguish a medication effect from an unproven supplement interaction. The label also cautions about restarting after a treatment interruption; ask the prescriber how to restart.
Evidence and practical considerations
Side effects & toxicity
The retained human null trial does not support treating CoQ10 as a demonstrated cause of excess hypotension with terazosin.
- Exact scope
- Oral terazosin with CoQ10 supplements; the inspected trial used 100 mg twice daily with unchanged background antihypertensive treatment. with Current RxNorm confirms terazosin RxCUI 37798 IN. Oral hydrochloride capsules provide equivalent terazosin 1, 2, 5 or 10 mg.
- Medication form and route
- Oral
What remains uncertain
- Abstract-only small trial, no terazosin-specific results and no harmful-hypotension signal; null result is not proof of universal safety.
Factors that may matter: Exact preparation and dose; Blood pressure and symptoms; Treatment initiation or dose change; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed terazosin hydrochloride capsules.
First-dose and postural hypotension/syncope; caution after dose escalation or restarting interrupted therapy.
How this applies: Exact ingredient through the stated labeled salt and oral formulation. Current RxNorm confirms terazosin RxCUI 37798 IN. Oral hydrochloride capsules provide equivalent terazosin 1, 2, 5 or 10 mg.
No automatic transfer of another alpha blocker’s doses or timing; exact label used.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 30 adults with metabolic syndrome and inadequately controlled BP on unchanged antihypertensives.
No significant improvement in primary 24-hour systolic or diastolic BP; some secondary diastolic-load measures improved. No clinically relevant safety changes.
How this applies: Exact preparation and endpoint boundaries retained; this is not a measured terazosin combination unless explicitly stated.
Abstract-only; no terazosin subgroup or demonstrated excess hypotension.
Source 3: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
terazosin is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: 30a4fe10579bb04b
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.